These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

518 related articles for article (PubMed ID: 31771980)

  • 1. NMR-based site-resolved profiling of β-amyloid misfolding reveals structural transitions from pathologically relevant spherical oligomer to fibril.
    Xiao Y; Matsuda I; Inoue M; Sasahara T; Hoshi M; Ishii Y
    J Biol Chem; 2020 Jan; 295(2):458-467. PubMed ID: 31771980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural Insight into an Alzheimer's Brain-Derived Spherical Assembly of Amyloid β by Solid-State NMR.
    Parthasarathy S; Inoue M; Xiao Y; Matsumura Y; Nabeshima Y; Hoshi M; Ishii Y
    J Am Chem Soc; 2015 May; 137(20):6480-3. PubMed ID: 25938164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Supramolecular structural constraints on Alzheimer's beta-amyloid fibrils from electron microscopy and solid-state nuclear magnetic resonance.
    Antzutkin ON; Leapman RD; Balbach JJ; Tycko R
    Biochemistry; 2002 Dec; 41(51):15436-50. PubMed ID: 12484785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence of fibril-like β-sheet structures in a neurotoxic amyloid intermediate of Alzheimer's β-amyloid.
    Chimon S; Shaibat MA; Jones CR; Calero DC; Aizezi B; Ishii Y
    Nat Struct Mol Biol; 2007 Dec; 14(12):1157-64. PubMed ID: 18059284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new structural model of Alzheimer's Aβ42 fibrils based on electron paramagnetic resonance data and Rosetta modeling.
    Gu L; Tran J; Jiang L; Guo Z
    J Struct Biol; 2016 Apr; 194(1):61-7. PubMed ID: 26827680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural insights into Aβ42 oligomers using site-directed spin labeling.
    Gu L; Liu C; Guo Z
    J Biol Chem; 2013 Jun; 288(26):18673-83. PubMed ID: 23687299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery and Identification of an Endogenous Metabolite of Tramiprosate and Its Prodrug ALZ-801 that Inhibits Beta Amyloid Oligomer Formation in the Human Brain.
    Hey JA; Kocis P; Hort J; Abushakra S; Power A; Vyhnálek M; Yu JY; Tolar M
    CNS Drugs; 2018 Sep; 32(9):849-861. PubMed ID: 30076539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural details of amyloid β oligomers in complex with human prion protein as revealed by solid-state MAS NMR spectroscopy.
    König AS; Rösener NS; Gremer L; Tusche M; Flender D; Reinartz E; Hoyer W; Neudecker P; Willbold D; Heise H
    J Biol Chem; 2021; 296():100499. PubMed ID: 33667547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Internalisation and toxicity of amyloid-β 1-42 are influenced by its conformation and assembly state rather than size.
    Vadukul DM; Maina M; Franklin H; Nardecchia A; Serpell LC; Marshall KE
    FEBS Lett; 2020 Nov; 594(21):3490-3503. PubMed ID: 32871611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EPR Studies of Aβ42 Oligomers Indicate a Parallel In-Register β-Sheet Structure.
    Jang C; Portugal Barron D; Duo L; Ma C; Seabaugh H; Guo Z
    ACS Chem Neurosci; 2024 Jan; 15(1):86-97. PubMed ID: 38109787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterizing amyloid-beta protein misfolding from molecular dynamics simulations with explicit water.
    Lee C; Ham S
    J Comput Chem; 2011 Jan; 32(2):349-55. PubMed ID: 20734314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The coexistence of an equal amount of Alzheimer's amyloid-β 40 and 42 forms structurally stable and toxic oligomers through a distinct pathway.
    Chang YJ; Chen YR
    FEBS J; 2014 Jun; 281(11):2674-87. PubMed ID: 24720730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural variation in amyloid-β fibrils from Alzheimer's disease clinical subtypes.
    Qiang W; Yau WM; Lu JX; Collinge J; Tycko R
    Nature; 2017 Jan; 541(7636):217-221. PubMed ID: 28052060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successive Stages of Amyloid-β Self-Assembly Characterized by Solid-State Nuclear Magnetic Resonance with Dynamic Nuclear Polarization.
    Potapov A; Yau WM; Ghirlando R; Thurber KR; Tycko R
    J Am Chem Soc; 2015 Jul; 137(25):8294-307. PubMed ID: 26068174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resveratrol inhibits beta-amyloid oligomeric cytotoxicity but does not prevent oligomer formation.
    Feng Y; Wang XP; Yang SG; Wang YJ; Zhang X; Du XT; Sun XX; Zhao M; Huang L; Liu RT
    Neurotoxicology; 2009 Nov; 30(6):986-95. PubMed ID: 19744518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding amyloid fibril nucleation and aβ oligomer/drug interactions from computer simulations.
    Nguyen P; Derreumaux P
    Acc Chem Res; 2014 Feb; 47(2):603-11. PubMed ID: 24368046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphic triple beta-sheet structures contribute to amide hydrogen/deuterium (H/D) exchange protection in the Alzheimer amyloid beta42 peptide.
    Ma B; Nussinov R
    J Biol Chem; 2011 Sep; 286(39):34244-53. PubMed ID: 21832091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural Reorganization Mechanism of the Aβ
    Dabas A; Goyal B
    ACS Chem Neurosci; 2024 Sep; 15(17):3136-3151. PubMed ID: 39158263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of Nucleated Conformational Conversion of Aβ42.
    Fu Z; Aucoin D; Davis J; Van Nostrand WE; Smith SO
    Biochemistry; 2015 Jul; 54(27):4197-207. PubMed ID: 26069943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. α-synuclein-assisted oligomerization of β-amyloid (1-42).
    Chau E; Kim JR
    Arch Biochem Biophys; 2022 Mar; 717():109120. PubMed ID: 35041853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.